IL123336A - Pharmaceutical compositions comprising diacerein rhein or a salt thereof for oral administration - Google Patents

Pharmaceutical compositions comprising diacerein rhein or a salt thereof for oral administration

Info

Publication number
IL123336A
IL123336A IL12333697A IL12333697A IL123336A IL 123336 A IL123336 A IL 123336A IL 12333697 A IL12333697 A IL 12333697A IL 12333697 A IL12333697 A IL 12333697A IL 123336 A IL123336 A IL 123336A
Authority
IL
Israel
Prior art keywords
diacerein
rhein
oral administration
pct
salt
Prior art date
Application number
IL12333697A
Other languages
English (en)
Other versions
IL123336A0 (en
Original Assignee
Negma Steba Internat Dev N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Negma Steba Internat Dev N V filed Critical Negma Steba Internat Dev N V
Publication of IL123336A0 publication Critical patent/IL123336A0/xx
Publication of IL123336A publication Critical patent/IL123336A/xx

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65H—HANDLING THIN OR FILAMENTARY MATERIAL, e.g. SHEETS, WEBS, CABLES
    • B65H23/00—Registering, tensioning, smoothing or guiding webs
    • B65H23/04—Registering, tensioning, smoothing or guiding webs longitudinally
    • B65H23/06—Registering, tensioning, smoothing or guiding webs longitudinally by retarding devices, e.g. acting on web-roll spindle
    • B65H23/10—Registering, tensioning, smoothing or guiding webs longitudinally by retarding devices, e.g. acting on web-roll spindle acting on running web
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B37/00—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding
    • B32B37/14—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers
    • B32B37/16—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers with all layers existing as coherent layers before laminating
    • B32B37/22—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers with all layers existing as coherent layers before laminating involving the assembly of both discrete and continuous layers
    • B32B37/223—One or more of the layers being plastic
    • B32B37/226—Laminating sheets, panels or inserts between two continuous plastic layers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B38/00—Ancillary operations in connection with laminating processes
    • B32B38/18—Handling of layers or the laminate
    • B32B38/1825—Handling of layers or the laminate characterised by the control or constructional features of devices for tensioning, stretching or registration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2309/00—Parameters for the laminating or treatment process; Apparatus details
    • B32B2309/06—Angles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Registering, Tensioning, Guiding Webs, And Rollers Therefor (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL12333697A 1996-07-04 1997-06-30 Pharmaceutical compositions comprising diacerein rhein or a salt thereof for oral administration IL123336A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1003503A NL1003503C2 (nl) 1996-07-04 1996-07-04 Farmaceutische samenstelling voor orale toediening.
PCT/EP1997/003405 WO1998001118A1 (fr) 1996-07-04 1997-06-30 Composition pharmaceutique pour administration par voie orale

Publications (2)

Publication Number Publication Date
IL123336A0 IL123336A0 (en) 1998-09-24
IL123336A true IL123336A (en) 2001-03-19

Family

ID=19763138

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12333697A IL123336A (en) 1996-07-04 1997-06-30 Pharmaceutical compositions comprising diacerein rhein or a salt thereof for oral administration

Country Status (16)

Country Link
US (1) US5952383A (de)
EP (1) EP0862423B1 (de)
JP (1) JP4209467B2 (de)
KR (1) KR980009519A (de)
CN (1) CN1196477C (de)
AT (1) ATE275945T1 (de)
AU (1) AU3263197A (de)
BR (1) BR9706537A (de)
CA (1) CA2231342C (de)
DE (1) DE69730688T2 (de)
ES (1) ES2230608T3 (de)
IL (1) IL123336A (de)
MX (1) MX9801727A (de)
NL (1) NL1003503C2 (de)
PL (1) PL189358B1 (de)
WO (1) WO1998001118A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2338946T3 (es) * 1998-02-13 2010-05-13 Nutramax Laboratories, Inc. Agentes y procedimientos para la proteccion, tratamiento y reparacion del tejido conjuntivo.
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
US20020128317A1 (en) * 2001-01-23 2002-09-12 Laboratories Negma Treatment of pathological conditions characterized by an increased IL-1 level
JP5296314B2 (ja) * 2003-07-17 2013-09-25 バナー ファーマキャップス，インコーポレイティド 制御放出製剤
GB0317869D0 (en) * 2003-07-30 2003-09-03 Disperse Ltd Improved drug delivery system
JP5096658B2 (ja) * 2003-10-06 2012-12-12 株式会社三協 生物学的利用能を向上させたソフトカプセル
US7775245B2 (en) 2005-04-08 2010-08-17 Air Products And Chemicals, Inc. Secure loop system and method for supply and delivery of product contained in a carrier
GB0523041D0 (en) * 2005-11-11 2005-12-21 Cyclacel Ltd Combination
GB0526419D0 (en) * 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
GB0622479D0 (en) * 2006-11-10 2006-12-20 Sosei R & D Ltd Novel salts and their therapeutic use
GB0625283D0 (en) * 2006-12-19 2007-01-24 Cyclacel Ltd Combination
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
CN100475201C (zh) * 2007-03-19 2009-04-08 上海慈瑞医药科技有限公司 二乙酰大黄酸缓释片的制备方法
CN101371823B (zh) * 2007-03-19 2010-09-15 上海慈瑞医药科技有限公司 二乙酰大黄酸缓释胶囊的制备工艺
EP2008651A1 (de) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Biologisch erodierbares Patch
FR2920991A1 (fr) * 2007-09-14 2009-03-20 Wockhardt Ltd Composition a base de diacerheine pour le traitement de l'arthrose
EP2471515A3 (de) * 2007-09-14 2012-12-26 Wockhardt Limited Rhein- oder Diacereinzusammensetzungen
WO2009040776A1 (en) * 2007-09-27 2009-04-02 Wockhardt Research Centre Self-emulsifying pharmaceutical compositions of rhein or diacerein
US20100285114A1 (en) * 2007-09-27 2010-11-11 Rahul Dabre Pharmaceutical compositions of rhein or diacerein
CA2926563A1 (en) 2007-09-27 2009-04-02 Wockhardt Research Centre Pharmaceutical compositions of rhein or diacerein
US20100018107A1 (en) * 2008-07-22 2010-01-28 Christensen Kurt L Method and means for controlling the population of mosquitoes in a non-toxic manner
AU2011340797B2 (en) * 2010-12-10 2017-08-10 Ns Technologies Pty Ltd Methods for forming miniemulsions and use thereof for delivering bioactive agents
US9610245B2 (en) 2011-03-14 2017-04-04 Drug Delivery Solutions Limited Ophthalmic composition
EP2793854B1 (de) 2011-12-23 2015-12-16 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulierungen aus flurbiprofen und diacerein
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat
IN201941031481A (de) * 2019-08-03 2021-02-05

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) * 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
US5225192A (en) * 1988-10-17 1993-07-06 Vectorpharma International S.P.A. Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
IT1189097B (it) * 1986-05-02 1988-01-28 Proter Spa Sali di diacetilreina e loro impiego terapeutico nel trattamento dell'artrosi
IT1197316B (it) * 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
IT1230566B (it) * 1988-10-17 1991-10-28 Vectorpharma Int Farmaci poco solubili supportati su sostanze polimeriche in forma atta all'aumento della velocita' di dissoluzione
EP1004318A3 (de) * 1991-06-21 2002-08-07 Takeda Chemical Industries, Ltd. Zyklodextrin-zusammensetzung
IT1256386B (it) * 1992-11-13 1995-12-04 Luigi Boltri Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo
GB9316923D0 (en) * 1993-08-13 1993-09-29 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
CN1196477C (zh) 2005-04-13
DE69730688D1 (de) 2004-10-21
IL123336A0 (en) 1998-09-24
CN1197388A (zh) 1998-10-28
ATE275945T1 (de) 2004-10-15
CA2231342A1 (fr) 1998-01-15
WO1998001118A1 (fr) 1998-01-15
EP0862423A1 (de) 1998-09-09
US5952383A (en) 1999-09-14
MX9801727A (es) 1998-11-30
PL325282A1 (en) 1998-07-20
PL189358B1 (pl) 2005-07-29
DE69730688T2 (de) 2005-09-22
KR980009519A (ko) 1998-04-30
AU3263197A (en) 1998-02-02
CA2231342C (fr) 2008-04-08
NL1003503C2 (nl) 1998-01-07
JP4209467B2 (ja) 2009-01-14
BR9706537A (pt) 1999-12-28
EP0862423B1 (de) 2004-09-15
ES2230608T3 (es) 2005-05-01
JPH11512115A (ja) 1999-10-19

Similar Documents

Publication Publication Date Title
IL123336A0 (en) Pharmaceutical compositions comprising diacerein rhein or a salt thereof for oral administration
HU9502624D0 (en) Methods for inhibiting bone loss with 3,4-diarylchroman
IS4187A (is) Ný lyfjablanda til inntöku um munn sem inniheldurnýtt magnesíumsalt ómeprasóls, aðferð við framleiðslu hennar og notkun
UA63993C2 (uk) Фармацевтична лікарська форма, що швидко тане в роті (варіанти) та спосіб формування гранул
IL125848A (en) Pharmaceutical compositions containing clopidogrel and aspirin and their use for the preparation of a medicine for the treatment of a pathology induced by platelet aggregation
EP0866656A4 (de) Inhibierung des alpha tumornekrose-faktors
YU2494A (sh) Farmaceutska formulacija za tretiranje zavisnosti od nikotina
NO964486L (no) Anvendelse av visse metanbisfosfonsyrederivater for å forhindre lösning av protese og protesemigrering
DE69525649D1 (de) Lamotrigin haltiges arzneimittel
DE69812086D1 (de) Glykosylierte-ginkgolid-derivate, ihre verwendung als arzneimitteln und pharmazeutische zubereitungen die sie enthalten
ZA935045B (en) Pharmacologically active alfa-(tertiary-aminomethyl)-ben-zenemethanol derivatives
GB2121277A (en) Preparations for combating colds and flu, containing iron salt and calcium lactate

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees